Major vault protein forms complexes with hypoxia-inducible factor (HIF)-1α and reduces HIF-1α level in ACHN human renal adenocarcinoma cells

被引:14
作者
Iwashita, Ken-ichi [1 ]
Ikeda, Ryuji [1 ]
Takeda, Yasuo [1 ]
Sumizawa, Tomoyuki [2 ]
Furukawa, Tatsuhiko [3 ]
Yamaguchi, Tatsuya [1 ]
Akiyama, Shin-ichi [3 ]
Yamada, Katsushi [1 ]
机构
[1] Kagoshima Univ, Dept Clin Pharm & Pharmacol, Grad Sch Med & Dent Sci, Kagoshima 890, Japan
[2] Univ Occupat & Environm Hlth, Dept Environm Toxicol, Inst Ind Ecol Sci, Kitakyushu, Fukuoka 807, Japan
[3] Kagoshima Univ, Dept Mol Oncol, Grad Sch Med & Dent Sci, Kagoshima 890, Japan
关键词
RESISTANCE-RELATED PROTEIN; MULTIDRUG-RESISTANCE; MAMMALIAN-CELLS; SMALL RNA; GENE; EXPRESSION; OXYGEN; DOMAIN; DISRUPTION; POLYMERASE;
D O I
10.1111/j.1349-7006.2010.01481.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Vaults are evolutionarily highly conserved ribonucleoprotein (RNP) particles with a hollow barrel-like structure. Although roles in multidrug resistance and innate immunity have been suggested, the physiological function of vaults remains unclear. Major vault protein (MVP), the main component of the vault particle, has been reported to be induced by hypoxia. However, there are no reports about the effect of vaults on cellular responses to hypoxia. We thus examined whether vaults are implicated in cellular responses to hypoxia. In this study, we focused on hypoxia-inducible factor-1 alpha (HIF-1 alpha), which is a master regulator of hypoxic responses, and found that: (i) MVP knockdown by RNA interference increases HIF-1 alpha protein levels induced by hypoxia and hypoxia mimetics; (ii) MVP knockdown does not affect HIF-1 alpha mRNA levels, but decreases the ubiquitination and degradation of HIF-1 alpha protein; and (iii) vaults form complexes with HIF-1 alpha, PHD2, and pVHL. Taken together, these results suggest that vaults function as scaffolds in HIF-1 alpha degradation pathway and promote the ubiquitination and degradation of HIF-1 alpha. (Cancer Sci 2010; 101: 920-926)
引用
收藏
页码:920 / 926
页数:7
相关论文
共 39 条
[1]   OS-9 interacts with hypoxia-inducible factor 1α and prolyl hydroxylases to promote oxygen-dependent degradation of HIF-1α [J].
Baek, JH ;
Mahon, PC ;
Oh, J ;
Kelly, B ;
Krishnamachary, B ;
Pearson, M ;
Chan, DA ;
Giaccia, AJ ;
Semenza, GL .
MOLECULAR CELL, 2005, 17 (04) :503-512
[2]   Spermidine/spermine-N1-acetyltransferase 2 is an essential component of the ubiquitin ligase complex that regulates hypoxia-inducible factor 1α [J].
Baek, Jin Hyen ;
Liu, Ye V. ;
McDonald, Karin R. ;
Wesley, Jacob B. ;
Hubbi, Maimon E. ;
Byun, Hweejo ;
Semenza, Gregg L. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (32) :23572-23580
[3]   A system for stable expression of short interfering RNAs in mammalian cells [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
SCIENCE, 2002, 296 (5567) :550-553
[4]   COP1, AN ARABIDOPSIS REGULATORY GENE, ENCODES A PROTEIN WITH BOTH A ZINC-BINDING MOTIF AND A G-BETA HOMOLOGOUS DOMAIN [J].
DENG, XW ;
MATSUI, M ;
WEI, N ;
WAGNER, D ;
CHU, AM ;
FELDMANN, KA ;
QUAIL, PH .
CELL, 1992, 71 (05) :791-801
[5]   A mammalian telomerase-associated protein [J].
Harrington, L ;
McPhail, T ;
Mar, V ;
Zhou, W ;
Oulton, R ;
Bass, MB ;
Arruda, I ;
Robinson, MO .
SCIENCE, 1997, 275 (5302) :973-977
[6]   Major vault protein does not play a role in chemoresistance or drug localization in a non-small cell lung cancer cell line [J].
Huffman, KE ;
Corey, DR .
BIOCHEMISTRY, 2005, 44 (07) :2253-2261
[7]   Hyperosmotic stress up-regulates the expression of major vault protein in SW620 human colon cancer cells [J].
Ikeda, Ryuji ;
Iwashita, Ken-ichi ;
Sumizawa, Tomoyuki ;
Beppu, Shun-ichi ;
Tabata, Sho ;
Tajitsu, Yusuke ;
Shimamoto, Yuichi ;
Yoshida, Kenichi ;
Furukawa, Tatsuhiko ;
Che, Xiao-Fang ;
Yamaguchi, Tatsuya ;
Ushiyama, Mina ;
Miyawaki, Akihiko ;
Takeda, Yasuo ;
Yamamoto, Masatatsu ;
Zhao, Hong-Ye ;
Shibayama, Yoshihiko ;
Yamada, Katsushi ;
Akiyama, Shin-ichi .
EXPERIMENTAL CELL RESEARCH, 2008, 314 (16) :3017-3026
[8]   Relationship of LRP-human major vault protein to in vitro and clinical resistance to anticancer drugs [J].
Izquierdo, MA ;
Scheffer, GL ;
Flens, MJ ;
Shoemaker, RH ;
Rome, LH ;
Scheper, RJ .
CYTOTECHNOLOGY, 1996, 19 (03) :191-197
[9]  
Izquierdo MA, 1996, INT J CANCER, V65, P230
[10]   Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation [J].
Jaakkola, P ;
Mole, DR ;
Tian, YM ;
Wilson, MI ;
Gielbert, J ;
Gaskell, SJ ;
von Kriegsheim, A ;
Hebestreit, HF ;
Mukherji, M ;
Schofield, CJ ;
Maxwell, PH ;
Pugh, CW ;
Ratcliffe, PJ .
SCIENCE, 2001, 292 (5516) :468-472